Clinical trial
A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In…
NCT00150709 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00150709 |
|---|---|
| Title | A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy |
| Official title | A Multi-Center, Open-Label, Long-Term, Follow-Up Study Of The Safety And Efficacy Of Levetiracetam (Ucb L059) In Children With Epilepsy |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Epilepsy, Partial |
| Intervention type | Drug |
| Interventions | Levetiracetam |
| Enrollment | 223 |
| Start date | Jan 26, 1998 |
| Primary completion | Jan 25, 2006 |
| Completion | Jan 25, 2006 |
| First posted | Sep 8, 2005 |
| Last update posted | Feb 9, 2024 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: